Abstract:Gene therapy following gene transfer into hematopoietic cells (CD34+) is now being investigated for several genetic disorders. We have applied a similar approach using interferon gene transfer for treatment of chronic myelogenous leukemia (CML). IFN-α produces a hematologic and cytogenetic response in CML with a survival advantage for cytogenetic responders. Therefore, we examined the effect of transient over- expression of IFN-α using the adenovirus gene transfer approach. The ability of the adenovirus (Adv)-IFN-α gene construct to transfect normal and CML stem cells, CD34+, was examined. The peripheral blood mononuclear fraction from patients with CML treated with G-CSF or GM-CSF/G-CSF was enriched in CD34+ cells. Adv- cytomegalovirus (pCMV) promoter driven IFN-α at multiple doses was assessed to transfect highly purified CD34+ cells in the presence of matrix protein and in co- cultures with the stromal adherent cell layer. The use of cytokines enhances Adv- mediated IFN-α gene transfer into stem cells. Southern blot analysis demonstrated that the Adv-pCMV-IFN-α construct and IFN-α were expressed in cultured CD34+. Transient expression of the IFN-α gene did not suppress proliferation of CD34+ progenitors, CFU-Meg, BFU-E or CFU-CM growth. Reverse transcriptase/polymerase chain reaction (RT/PCR) analysis of RNA from CFU-GM progenitor cells demonstrated transient IFN-α mRNA expression in CD34+ cells. Immunoassay of IFN-α shows that IFN-α suggests that selective expression of IFN-α may be beneficial for CML therapy. We also report on the establishment of novel conditions which permit high efficiency of the retrovirus IFN-α gene into CD34+ cells. Stem cells transfected with retrovirus were infused intravenously to irradiated mice and spleen colony forming units were evaluated for IFN-α marked clones by Southern blot analysis. These studies demonstrate that the overexpression of IFN-α gene can be used suppression of K562 cell proliferation and suggest its possible use as gene therapy of CML. For permanent transfection, we constructed two IFNα cDNA-containing retroviral vectors LSN-IFNα was constructed by cloning human IFNα cDNA at the downstream of the 5′ long terminal repeat (LTR) promoter of the retroviral vector LXSN. Retrovirus-containing supernatants from PA317 cell line was used to infect NIH3T3 fibroblasts and K562 cells. The IFNα gene expression in transfected cells was confirmed by Northern Blot, RT-PCR, radioimmunoassay (RIA), and biological assay. Retroviral mediated IFN-α gene transfer infection results showed that cell proliferation and cell viability were significantly suppressed in LSN-IFNαa-infected K562 cells as compared to LXSN-infected K562. Furthermore, we found that retroviral mediated IFN-α causes upregulation of adhesion molecules such as VLA-4.

Adenovirus-Mediated Interferon-Gamma Transfer Inhibits Growth Of Transplanted Htlv-I Tax Tumors In Mice

ANTITUMOR EFFECTS OF HUMAN IL-15 GENE MODIFIED LUNG CANCER CELL LINE

Effects of gamma-interferon gene-modified hepatocytes on murine implanted liver carcinoma

Antitumor Effects Of Interleukin-18 Gene-Modified Hepatocyte Cell Line On Implanted Liver Carcinoma

In Vivo Tumorigenesis, Osteolytic Sarcomas, and Tumorigenic Cell Lines from Transgenic Mice Expressing the Human T-Lymphotropic Virus Type 1 (HTLV-1) Tax Viral Oncogene

Adenovirally Delivered IFN-β Exerts Antitumor Effects Through Transient T-lymphocyte Depletion and Ag-specific T-cell Proliferation.

Tumor immunity against adult T-cell leukemia

Induction of potent anti-tumor immunity by direct injection of Ad-LIGHT at the site of tumor inoculation.

Rerovirus Mediated Hsv-Tk Gene Transfer Can Influence The Function Of Human T-Lymphocyte

Interferon-β gene therapy inhibits tumor formation and causes regression of established tumors in immune-deficient mice

Cytotoxic T Lymphocyte Antigen 4 Decreases Humoral and Cellular Immunity by Adenovirus to Enhance Target GFP Gene Transfer in C57BL/6 Mice

HTLV-1 Tax transgenic mice develop spontaneous osteolytic bone metastases prevented by osteoclast inhibition

Constitutive Activation of Different Jak Tyrosine Kinases in Human T Cell Leukemia Virus Type 1 (HTLV-1) Tax Protein or Virus-Transformed Cells.

Dynamic Distribution and Expression in Vivo of the Human Interferon Gamma Gene Delivered by Adenoviral Vector.

Essential Role of Human T Cell Leukemia Virus Type 1 orf-I in Lethal Proliferation of CD4+ Cells in Humanized Mice

Effect of Retrovirus and Adenovirus Mediated Interferon Gene Transfer on Hematopoietic Progenitor Cell Growth

Inhibition of tumor necrosis factor alpha decreases inflammation and prolongs adenovirus gene expression in lung and liver

Anti-tumor immunity elicited by direct intratumoral administration of a recombinant adenovirus expressing either IL-28A/IFN-λ2 or IL-29/IFN-λ1

Genetically engineered Newcastle disease virus expressing human interferon-λ1 induces apoptosis in gastric adenocarcinoma cells and modulates the Th1/Th2 immune response

Alphavirus-Driven Interferon Gamma (IFNg) Expression Inhibits Tumor Growth in Orthotopic 4T1 Breast Cancer Model

Enhanced cell-mediated cytotoxicity by interferon-gamma and interleukin-2 against syngeneic murine mammary adenocarcinoma